No Data
No Data
Maxim Group Initiates Nuvectis Pharma(NVCT.US) With Buy Rating, Announces Target Price $17
Maxim Initiates Nuvectis Pharma at Buy With $17 Price Target
Express News | Nuvectis Pharma Announces Upcoming Presentations for Nxp900 at the 2025 American Association for Cancer Research Meeting
Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2025 American Association for Cancer Research Meeting
Laidlaw Initiates Nuvectis Pharma(NVCT.US) With Buy Rating, Announces Target Price $19
$NVCT Stock Is up 8% Today. Here's What We See in Our Data.